Kristian Humer

Kristian joined Viridian as Chief Financial Officer and Chief Business Officer in 2021.  He also serves on the board of directors at Sensei Biotherapeutics, Inc.  Prior to joining Viridian, Kristian served for 11 years at Citigroup, most recently as a Managing Director, helping to lead the biopharma coverage effort within their healthcare investment banking group. In this role, Kristian worked with a variety of biopharma management teams and boards on a range of strategic matters, including capital and financing strategy, executing equity and equity linked financings, and leading buy- and sell-side transactions. Prior to Citigroup, Kristian held roles at Lehman Brothers, UBS and Merrill Lynch. 

Kristian holds an MBA from Duke University’s Fuqua School of Business and a BA degree in Accounting & Economics from the University of Reading.